Document is current
Any future updates will be listed below
-
Authors
Klein, Dominik https://orcid.org/0000-0002-7334-3501
Palla, Giovanni
Lange, Marius https://orcid.org/0000-0002-4846-1266
Klein, Michal
Piran, Zoe https://orcid.org/0000-0003-0241-8948
Gander, Manuel
Meng-Papaxanthos, Laetitia
Sterr, Michael
Saber, Lama https://orcid.org/0009-0004-0297-050X
Jing, Changying https://orcid.org/0000-0002-0671-4114
Bastidas-Ponce, Aimée
Cota, Perla
Tarquis-Medina, Marta
Parikh, Shrey
Gold, Ilan
Lickert, Heiko https://orcid.org/0000-0002-4597-8825
Bakhti, Mostafa https://orcid.org/0000-0002-2307-1122
Nitzan, Mor https://orcid.org/0000-0003-0074-9196
Cuturi, Marco
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
- License Information
-
More Information
Article History
Received: 17 May 2023
Accepted: 25 November 2024
First Online: 22 January 2025
Competing interests
: F.J.T. consults for Immunai, Singularity Bio, CytoReason, Cellarity and Omniscope, and has ownership interest in Dermagnostix and Cellarity. The remaining authors declare no competing interests.
